Abstract
The estrogen-related receptors (ERRs), comprising ERRα, ERRβ and ERRγ, are the members of the nuclear receptor superfamily, which have been functionally implicated in estrogen signal pathway in various patterns. However, no natural ligand of ERRs has been identified to data, so identification of the synthetic modulators (inverse agonist and agonist) of ERRs would be highly effective in the treatment of estrogen-related pathologies, such as diabetes, breast cancer and osteoporosis. This review summarizes the structures and biological functions of ERR subtypes, and the progress in designing the small molecular modulators of ERRs as well as the detailed description of available co-crystal structures of the LBD of ERRs in three distinct states: unligand, inverse agonist bound, and agonist bound.
Keywords: Estrogen-related receptors (ERRs), ERRα, ERRγ, Modulators, Inverse agonist, Agonist, Biological Function, LBD, unligand, agonist bound, unligand, agonist bound
Current Pharmaceutical Design
Title:Recent Advance in the Design of Small Molecular Modulators of Estrogen-Related Receptors
Volume: 18 Issue: 23
Author(s): Xiaoyun Lu, Lijie Peng, Man Lv and Ke ding
Affiliation:
Keywords: Estrogen-related receptors (ERRs), ERRα, ERRγ, Modulators, Inverse agonist, Agonist, Biological Function, LBD, unligand, agonist bound, unligand, agonist bound
Abstract: The estrogen-related receptors (ERRs), comprising ERRα, ERRβ and ERRγ, are the members of the nuclear receptor superfamily, which have been functionally implicated in estrogen signal pathway in various patterns. However, no natural ligand of ERRs has been identified to data, so identification of the synthetic modulators (inverse agonist and agonist) of ERRs would be highly effective in the treatment of estrogen-related pathologies, such as diabetes, breast cancer and osteoporosis. This review summarizes the structures and biological functions of ERR subtypes, and the progress in designing the small molecular modulators of ERRs as well as the detailed description of available co-crystal structures of the LBD of ERRs in three distinct states: unligand, inverse agonist bound, and agonist bound.
Export Options
About this article
Cite this article as:
Lu Xiaoyun, Peng Lijie, Lv Man and ding Ke, Recent Advance in the Design of Small Molecular Modulators of Estrogen-Related Receptors, Current Pharmaceutical Design 2012; 18 (23) . https://dx.doi.org/10.2174/138161212801227113
DOI https://dx.doi.org/10.2174/138161212801227113 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain
CNS & Neurological Disorders - Drug Targets Omega-3 Fatty Acids for Nutrition and Medicine: Considering Microalgae Oil as a Vegetarian Source of EPA and DHA
Current Diabetes Reviews Stem Cells as Delivery Vehicles for Oncolytic Adenoviral Virotherapy
Current Gene Therapy In-Vitro Antiproliferative Activity of New Tetrahydroisoquinolines (THIQs) on Ishikawa Cells and their 3D Pharmacophore Models
Letters in Drug Design & Discovery Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research Direction
CNS & Neurological Disorders - Drug Targets Medicinal Plants for the Prevention and Treatment of Bacterial Infections
Current Pharmaceutical Design Regulation of Hepatic Transporters by Xenobiotic Receptors
Current Drug Metabolism Capillary Electrophoresis with Mass Spectrometry: Applications to Metabolomic Analysis
Current Metabolomics Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth,Angiogenesis and Metastasis
Current Pharmaceutical Design COX-2, Cell Proliferation and PMA in Head-and-Neck Cancer Cells
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Erythropoietin Enhances the Cytotoxic Effect of Hydrogen Peroxide on Colon Cancer Cells
Current Pharmaceutical Biotechnology Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma
Endocrine, Metabolic & Immune Disorders - Drug Targets NF-κ B and Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Enteric Neurons and Plexitis for the Management of Inflammatory Bowel Disease
Current Drug Targets Taurine and the Relevance of Supplementation in Humans, in Health and Disease
Current Nutrition & Food Science Gemcitabine: A Critical Nucleoside for Cancer Therapy
Current Medicinal Chemistry Probiotics and Oral Health
Current Pharmaceutical Design The High Throughput Biomedicine Unit at the Institute for Molecular Medicine Finland: High Throughput Screening Meets Precision Medicine
Combinatorial Chemistry & High Throughput Screening Xenobiotic Sulphation and its Variability During Inflammation: a Factor in Adverse Drug Reactions?
Current Drug Metabolism Influence of Leptin on Immunity
Current Immunology Reviews (Discontinued)